ArticleOncotarget2017
Erythropoietin drives breast cancer progression by activation of its receptor EPOR.
Ka Kui Chan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papertrialcites it
ArticleOncotarget2017
Ka Kui Chan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.